CareLit Fachartikel

Risk of not receiving 2nd line therapy is high in EGFR mt+ patients: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ patients

J Roeper, M Falk, S Schatz, M Tiemann, S Sackmann, D Ukena, C Wesseler, G Wiest, L Heukamp, F Griesinger · Pneumologie · 2019 · Heft S 01 S 01

Dokument
1194711
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
J Roeper, M Falk, S Schatz, M Tiemann, S Sackmann, D Ukena, C Wesseler, G Wiest, L Heukamp, F Griesinger
Ausgabe
Heft S 01 S 01 / 2019
Jahrgang 73
Seiten
–
Erschienen: 2019-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-1678025

Zusammenfassung

Risk of not receiving 2nd line therapy is high in EGFR mt+ patients: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ patients

Schlagworte

Patients Receiving Therapy World Certified Cancer Centers Treatment Sequence Pneumologie